CapsoVision, Inc. Common Stock (CV) - Total Liabilities
Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has total liabilities worth $4.90 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of CapsoVision, Inc. Common Stock to assess how effectively this company generates cash.
CapsoVision, Inc. Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how CapsoVision, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See net assets of CapsoVision, Inc. Common Stock for net asset value and shareholders' equity analysis.
CapsoVision, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hitron Technologies Inc
TW:2419
|
Taiwan | NT$4.61 Billion |
|
Evolent Health Inc
NYSE:EVH
|
USA | $1.61 Billion |
|
Kingsway Financial Services Inc
NYSE:KFS
|
USA | $199.31 Million |
|
Selena FM S.A.
WAR:SEL
|
Poland | zł667.99 Million |
|
FS Bancorp Inc
NASDAQ:FSBW
|
USA | $2.89 Billion |
|
Sunny Friend Environmental Technology Co Ltd
TW:8341
|
Taiwan | NT$4.29 Billion |
|
Rana Gruber AS
OL:RANA
|
Norway | Nkr783.91 Million |
|
XINTE ENERGY CO. CL.H YC1
F:9M7
|
Germany | €46.84 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down CapsoVision, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of CapsoVision, Inc. Common Stock.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CapsoVision, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CapsoVision, Inc. Common Stock (2023–2025)
The table below shows the annual total liabilities of CapsoVision, Inc. Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.90 Million | -96.65% |
| 2024-12-31 | $146.31 Million | +11.37% |
| 2023-12-31 | $131.37 Million | -- |
About CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more